Sleep Number Announces Second Quarter 2023 Results

In this article:
  • Second quarter net sales were $459 million; demand down mid-single digits versus the prior year

  • Reports second quarter diluted EPS of $0.03

  • 2023 EPS outlook updated to a range of $1.25 to $1.75 per share

  • Announces the appointment of Francis Lee to Executive Vice President and Chief Financial Officer

MINNEAPOLIS, July 27, 2023--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended July 1, 2023.

"As we continue to navigate a challenging macro environment, our business is well positioned for growth. Demand has steadily improved year-to-date, and we expect this trend to continue in the back-half of the year as we benefit from the launch of our entire next generation smart bed portfolio, the Climate360 smart bed, and the advancement of our ‘Sleep Next Level’ advertising campaign with the start of the NFL season," said Shelly Ibach, Chair, President and CEO, Sleep Number. "We have taken actions across the business to drive efficiencies and remain on track to expand margins and generate more than $100 million in cash from operations in 2023."

Today, Sleep Number also announced the appointment of Francis Lee to Executive Vice President and Chief Financial Officer. Details can be found on the Sleep Number newsroom.

Second Quarter Overview

  • Net sales decreased 16% to $459 million, with demand down mid-single digits; demand improved throughout the second quarter, although slightly below our expectations

  • Gross margin was 57.6% and in line with our expectations; as a reminder prior year second quarter results benefitted from the delivery of more than $100 million in margin-rich backlog

  • Operating expenses were reduced by $22 million to $253 million compared with $275 million last year

  • Earnings per diluted share of $0.03 compared with $1.54 for the same period last year

Year-to-Date Overview

  • Net sales decreased 8% to $985 million, with demand down high-single digits versus prior year

  • Gross profit decreased to $575 million compared with $627 million for the prior year; gross margin rate of 58.3% was consistent with the same period last year and up 290 bp versus the back half of last year

  • Operating income of $37 million compared with $54 million last year, with an 8% decline in gross margin dollars, partially offset by a $36 million reduction in operating expenses

  • Earnings per diluted share of $0.54 compared with $1.60 for the same period last year

Cash Flows Overview

  • Net cash from operating activities of $19 million for the first six months of the year, compared with $29 million for the same period last year

  • Leverage ratio of 4.7x EBITDAR at the end of the second quarter versus covenant maximum of 5.0x

  • Adjusted ROIC of 12.3% for the trailing twelve months

Financial Outlook

The company updated its full-year 2023 diluted EPS outlook to a range of $1.25 to $1.75. The 2023 outlook assumes net sales are down low to mid-single digits versus the prior year and gross margin improvement of more than 150 basis points versus 2022. The company expects to generate more than $100 million of operating cash flow for the year and positive free cash flows. The company anticipates 2023 capital expenditures of $50 million to $60 million.

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation

Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 14.5 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 21 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of smart sleepers are loyal brand advocates. And our nearly 5,000 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in 670 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number store near you, our newsroom. and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the company’s financial outlook for full-year 2023, including diluted EPS, are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future economic conditions and consumer sentiment; bank failures or other events affecting financial institutions; increases in interest rates, which have increased the cost of servicing the company’s indebtedness; availability of attractive and cost-effective consumer credit options; operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages; Sleep Number’s dependence on, and ability to maintain strong working relationships with key suppliers and third parties; rising commodity costs or third-party logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions; risks of disruption due to health epidemics or pandemics, such as the COVID-19 pandemic; regional risks related to having global operations and suppliers, including climate and other disasters; the effectiveness of the company’s marketing strategy and promotional efforts; the execution of Sleep Number’s Total Retail distribution strategy; ability to achieve and maintain high levels of product quality; ability to improve and expand Sleep Number’s product line and execute successful new product introductions; ability to prevent third parties from using the company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand; ability to compete; risks of disruption in the operation of any of the company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations; the company’s ability to comply with existing and changing government regulation; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; the company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel; the volatility of Sleep Number stock; environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and the company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto.​ Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

Three Months Ended

July 1,
2023

% of

Net Sales

July 2,
2022

% of

Net Sales

Net sales

$

458,789

100.0%

$

549,073

100.0%

Cost of sales

194,544

42.4%

224,128

40.8%

Gross profit

264,245

57.6%

324,945

59.2%

Operating expenses:

Sales and marketing

197,779

43.1%

220,490

40.2%

General and administrative

39,795

8.7%

38,727

7.1%

Research and development

15,445

3.4%

15,817

2.9%

Total operating expenses

253,019

55.1%

275,034

50.1%

Operating income

11,226

2.4%

49,911

9.1%

Interest expense, net

9,948

2.2%

3,619

0.7%

Income before income taxes

1,278

0.3%

46,292

8.4%

Income tax expense

524

0.1%

11,359

2.1%

Net income

$

754

0.2%

$

34,933

6.4%

Net income per share – basic

$

0.03

$

1.56

Net income per share – diluted

$

0.03

$

1.54

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding

22,460

22,355

Dilutive effect of stock-based awards

42

358

Diluted weighted-average shares outstanding

22,502

22,713

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

Six Months Ended

July 1,
2023

% of

Net Sales

July 2,
2022

% of

Net Sales

Net sales

$

985,316

100.0%

$

1,076,203

100.0%

Cost of sales

410,806

41.7%

448,960

41.7%

Gross profit

574,510

58.3%

627,243

58.3%

Operating expenses:

Sales and marketing

428,267

43.5%

460,749

42.8%

General and administrative

79,196

8.0%

80,046

7.4%

Research and development

29,888

3.0%

32,122

3.0%

Total operating expenses

537,351

54.5%

572,917

53.2%

Operating income

37,159

3.8%

54,326

5.0%

Interest expense, net

19,050

1.9%

5,746

0.5%

Income before income taxes

18,109

1.8%

48,580

4.5%

Income tax expense

5,890

0.6%

11,573

1.1%

Net income

$

12,219

1.2%

$

37,007

3.4%

Net income per share – basic

$

0.55

$

1.64

Net income per share – diluted

$

0.54

$

1.60

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding

22,378

22,558

Dilutive effect of stock-based awards

165

594

Diluted weighted-average shares outstanding

22,543

23,152

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited – in thousands, except per share amounts)

subject to reclassification

July 1,
2023

December 31,
2022

Assets

Current assets:

Cash and cash equivalents

$

1,798

$

1,792

Accounts receivable, net of allowances of $1,475 and $1,267, respectively

24,102

26,005

Inventories

121,446

114,034

Prepaid expenses

21,029

16,006

Other current assets

40,142

39,921

Total current assets

208,517

197,758

Non-current assets:

Property and equipment, net

191,067

200,605

Operating lease right-of-use assets

399,989

397,755

Goodwill and intangible assets, net

67,086

68,065

Deferred income taxes

16,230

7,958

Other non-current assets

82,266

81,795

Total assets

$

965,155

$

953,936

Liabilities and Shareholders’ Deficit

Current liabilities:

Borrowings under revolving credit facility

$

483,800

$

459,600

Accounts payable

152,205

176,207

Customer prepayments

58,498

73,181

Accrued sales returns

25,476

25,594

Compensation and benefits

38,934

31,291

Taxes and withholding

23,356

23,622

Operating lease liabilities

82,439

79,533

Other current liabilities

57,054

60,785

Total current liabilities

921,762

929,813

Non-current liabilities:

Operating lease liabilities

356,044

356,879

Other non-current liabilities

106,490

105,421

Total non-current liabilities

462,534

462,300

Total liabilities

1,384,296

1,392,113

Shareholders’ deficit:

Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

Common stock, $0.01 par value; 142,500 shares authorized, 22,214 and 22,014 shares issued and outstanding, respectively

222

220

Additional paid-in capital

11,997

5,182

Accumulated deficit

(431,360

)

(443,579

)

Total shareholders’ deficit

(419,141

)

(438,177

)

Total liabilities and shareholders’ deficit

$

965,155

$

953,936

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited – in thousands)

subject to reclassification

Six Months Ended

July 1,
2023

July 2,
2022

Cash flows from operating activities:

Net income

$

12,219

$

37,007

Adjustments to reconcile net income to net cash provided by

operating activities:

Depreciation and amortization

36,749

31,975

Stock-based compensation

9,890

8,043

Net loss on disposals and impairments of assets

181

179

Deferred income taxes

(8,272

)

(3,794

)

Changes in operating assets and liabilities:

Accounts receivable

1,903

(2,898

)

Inventories

(7,412

)

(15,674

)

Income taxes

1,808

4,368

Prepaid expenses and other assets

(5,824

)

6,266

Accounts payable

(10,244

)

(1,713

)

Customer prepayments

(14,683

)

(14,754

)

Accrued compensation and benefits

7,594

(17,789

)

Other taxes and withholding

(2,074

)

971

Other accruals and liabilities

(3,115

)

(3,496

)

Net cash provided by operating activities

18,720

28,691

Cash flows from investing activities:

Purchases of property and equipment

(29,899

)

(36,559

)

Proceeds from sales of property and equipment

23

Issuance of note receivable

(435

)

Net cash used in investing activities

(30,334

)

(36,536

)

Cash flows from financing activities:

Net increase in short-term borrowings

14,693

70,836

Repurchases of common stock

(3,501

)

(63,644

)

Proceeds from issuance of common stock

428

585

Debt issuance costs

(42

)

Net cash provided by financing activities

11,620

7,735

Net increase (decrease) in cash and cash equivalents

6

(110

)

Cash and cash equivalents, at beginning of period

1,792

2,389

Cash and cash equivalents, at end of period

$

1,798

$

2,279

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Supplemental Financial Information

(unaudited)

Three Months Ended

Six Months Ended

July 1,
2023

July 2,
2022

July 1,
2023

July 2,
2022

Percent of sales:

Retail stores

87.7

%

89.4

%

87.4

%

86.9

%

Online, phone, chat and other

12.3

%

10.6

%

12.6

%

13.1

%

Total Company

100.0

%

100.0

%

100.0

%

100.0

%

Sales change rates:

Retail comparable-store sales

(20

%)

10

%

(10

%)

(3

%)

Online, phone and chat

(3

%)

2

%

(12

%)

4

%

Total Retail comparable sales change

(18

%)

9

%

(10

%)

(2

%)

Net opened/closed stores and other

2

%

4

%

2

%

4

%

Total Company

(16

%)

13

%

(8

%)

2

%

Stores open:

Beginning of period

671

653

670

648

Opened

7

10

19

23

Closed

(6

)

(4

)

(17

)

(12

)

End of period

672

659

672

659

Other metrics:

Average sales per store ($ in 000's) 1

$

3,089

$

3,526

Average sales per square foot 1

$

1,007

$

1,172

Stores > $2 million net sales 2

71

%

82

%

Stores > $3 million net sales 2

31

%

45

%

Average revenue per smart bed unit 3

$

5,990

$

6,485

$

5,913

$

5,601

1

Trailing twelve months Total Retail comparable sales per store open at least one year.

2

Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).

3

Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

Three Months Ended

Trailing Twelve Months Ended

July 1,
2023

July 2,
2022

July 1,
2023

July 2,
2022

Net income

$

754

$

34,933

$

11,822

$

101,869

Income tax expense

524

11,359

6,602

30,442

Interest expense

9,948

3,619

32,289

9,406

Depreciation and amortization

18,304

15,920

71,318

61,857

Stock-based compensation

5,252

3,910

15,071

18,872

Asset impairments

170

80

294

266

Adjusted EBITDA

$

34,952

$

69,821

$

137,396

$

222,712

Free Cash Flow

(in thousands)

Three Months Ended

Trailing Twelve Months Ended

July 1,
2023

July 2,
2022

July 1,
2023

July 2,
2022

Net cash provided by operating activities

$

139

$

4,133

$

26,167

$

167,281

Subtract: Purchases of property and equipment

14,343

16,955

62,794

71,447

Free cash flow

$

(14,204

)

$

(12,822

)

$

(36,627

)

$

95,834

Calculation of Net Leverage Ratio under Revolving Credit Facility

(in thousands)

Trailing Twelve Months Ended

July 1,
2023

July 2,
2022

Borrowings under revolving credit facility

$

483,800

$

443,300

Outstanding letters of credit

7,147

5,947

Finance lease obligations

361

479

Consolidated funded indebtedness

$

491,308

$

449,726

Capitalized operating lease obligations 1

675,108

642,213

Total debt including capitalized operating lease obligations (a)

$

1,166,416

$

1,091,939

Adjusted EBITDA (see above)

$

137,396

$

222,712

Consolidated rent expense

112,518

107,035

Consolidated EBITDAR (b)

$

249,914

$

329,747

Net Leverage Ratio under revolving credit facility (a divided by b)

4.7 to 1.0

3.3 to 1.0

1

A multiple of six times annual rent expense is used as an estimate for capitalizing our operating lease obligations in accordance with our credit facility.

Note - Our Adjusted EBITDA and EBITDAR calculations, Free Cash Flow data and Calculation of Net Leverage Ratio under Revolving Credit Facility are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Return on Invested Capital (Adjusted ROIC)

(in thousands)

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

Trailing Twelve Months Ended

July 1,
2023

July 2,
2022

Adjusted net operating profit after taxes (Adjusted NOPAT)

Operating income

$

50,713

$

141,718

Add: Operating lease interest 1

27,040

25,079

Less: Income taxes 2

(21,993

)

(39,798

)

Adjusted NOPAT

$

55,760

$

126,999

Average adjusted invested capital

Total deficit

$

(419,141

)

$

(442,962

)

Add: Long-term debt 3

484,161

443,779

Add: Operating lease obligations 4

438,483

420,516

Total adjusted invested capital at end of period

$

503,503

$

421,333

Average adjusted invested capital 5

$

452,573

$

363,986

Adjusted ROIC 6

12.3

%

34.9

%

1

Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.

2

Reflects annual effective income tax rates, before discrete adjustments, of 28.3% and 23.9% for July 1, 2023 and July 2, 2022, respectively.

3

Long-term debt includes existing finance lease liabilities.

4

Reflects operating lease liabilities included in our financial statements under ASC 842.

5

Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.

6

Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

Note - the Company's adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842. The prior period has been updated to reflect this calculation.

GAAP - generally accepted accounting principles in the U.S.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230727874608/en/

Contacts

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; julie.elepano@sleepnumber.com

Advertisement